Biofrontera AG (ETR:B8FK)
Germany · Delayed Price · Currency is EUR 2.400
-0.010 (-0.41%)
May 8, 2026, 5:43 PM CET
Biofrontera AG Market Cap
Biofrontera AG has a market cap or net worth of €14.83 million as of May 8, 2026. Its market cap has increased by 3.83% in one year.
Market Cap
14.83M
Enterprise Value
11.29M
Revenue
13.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.40
Market Cap Chart
Since October 31, 2006, Biofrontera AG's market cap has decreased from 38.05M to 14.83M, a decrease of -61.03%. That is a compound annual growth rate of -4.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 14.83M | - |
| Dec 30, 2025 | 14.83M | 13.49% |
| Dec 30, 2024 | 13.07M | -48.94% |
| Dec 29, 2023 | 25.59M | -73.70% |
| Dec 30, 2022 | 97.31M | 15.92% |
| Dec 30, 2021 | 83.94M | -42.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 49.06B |
| Siemens Healthineers AG | 37.53B |
| Bayer Aktiengesellschaft | 36.33B |
| Fresenius SE & Co. KGaA | 23.07B |
| FamiCord AG | 71.64M |
| Pentixapharm Holding AG | 53.53M |
| MeVis Medical Solutions AG | 42.22M |
| aap Implantate AG | 28.65M |